Osteoporosis Drugs Global Market Opportunities And Strategies To 2034
상품코드:1695928
리서치사:The Business Research Company
발행일:2025년 03월
페이지 정보:영문 317 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 골다공증 치료제 시장 규모는 2019년에 114억 3,616만 달러에 달했습니다. 이 시장은 2024년까지 CAGR 2.00% 이상으로 성장하고 있습니다.
실적 기간 중 건강 보험의 확대는 골다공증 치료제 시장의 성장을 지원했습니다. 건강 보험은 의료 비용을 절감하고 골다공증 치료제의 구매 용이성과 접근성을 향상시킵니다. 생물제제 및 주사제와 같은 첨단 치료제에 대한 보험 적용은 환자 도입을 촉진하여 시장 성장을 지원합니다. 보험은 경제적 장벽을 완화함으로써 적시에 진단과 치료를 촉진하고, 혁신적인 골다공증 치료제에 대한 수요를 촉진하여 시장 잠재력을 확대합니다. 예를 들어 인도의 온라인 보험 애그리게이터이자 핀테크 플랫폼인 PolicyBazaar에 따르면 인도에서 정기보험에 가입하는 여성의 수가 크게 증가하여 지난 2년 동안 80% 증가했다고 합니다. 또한 스위스 리에 따르면 2023-24년 보험 보급률은 인도에서 3.8%, 전 세계에서 6.5%를 나타낼 것으로 예측됩니다. 따라서 의료보험의 확대가 골다공증 치료제 시장의 성장을 촉진했습니다.
세계의 골다공증 치료제 시장에 대해 조사했으며, 시장의 개요와 유형별, 투여 방법별, 유통 채널별, 용도별, 지역·국가별 동향 및 시장에 참여하는 기업의 개요 등을 제공하고 있습니다.
목차
제1장 개요
제2장 목차
제3장 표 리스트
제4장 도표
제5장 리포트 구성
제6장 시장의 특징
일반적인 시장의 정의
요약
골다공증 치료제 시장의 정의와 세분화
유형별 시장 세분화
비스포스포네이트
선택적 에스트로겐 수용체 모듈레이터(SERM)
RANK 리간드 저해제
부갑상선 호르몬 요법
칼시토닌
스클레로스틴 저해제
기타
투여 방법별 시장 세분화
경구
주사
유통 채널별 시장 세분화
소매 약국
병원 약국
온라인 판매
용도별 시장 세분화
원발성 골다공증
연발성 골다공증
제7장 주요 시장 동향
환자 결과를 개선하는 혁신적인 골다공증 치료가 발매
혁신적인 어프로치와 규제기관의 승인이 치료의 진보를 추진
골다공증 치료의 개선을 향한 표적 치료 옵션별 첨단 치료
제8장 골다공증 치료제 시장 - 거시경제 시나리오
제9장 세계 시장 규모와 성장
시장 규모
시장 성장 실적, 2019-2024년
시장 성장 예측, 2024-2029년, 2034년
제10장 세계의 골다공증 치료제 시장 세분화
세계의 골다공증 치료제 시장, 유형별 세분화, 실적 및 예측, 2019-2024년, 2029년 예측, 2034년 예측
세계의 골다공증 치료제 시장, 투여법별 세분화, 실적 및 예측, 2019-2024년, 2029년, 2034년
세계의 골다공증 치료제 시장, 유통 채널별 세분화, 실적 및 예측, 2019-2024년, 2029년 예측, 2034년 예측
세계의 골다공증 치료제 시장, 용도별 세분화, 실적 및 예측, 2019-2024년, 2029년 예측, 2034년 예측
제11장 골다공증 치료제 시장, 지역별·국가별 분석
세계의 골다공증 치료제 시장, 지역별, 실적 및 예측, 2019-2024년, 2029년 예측, 2034년 예측
세계의 골다공증 치료제 시장, 국가별, 실적 및 예측, 2019-2024년, 2029년 예상, 2034년 예상
제12장 아시아태평양 시장
제13장 서유럽 시장
제14장 동유럽 시장
제15장 북미 시장
제16장 남미 시장
제17장 중동 시장
제18장 아프리카 시장
제19장 경쟁 구도와 기업 개요
기업 개요
Amgen Inc.
Eli Lilly and Company
Pfizer Inc.
Eisai Co., Ltd.
Apotex Inc.
제20장 기타 대기업과 혁신적 기업
AbbVie Inc.
Novartis AG
Sanofi S.A.
GSK plc
Daiichi Sankyo Company, Limited
F. Hoffmann La Roche Ltd.
Teva Pharmaceutical Industries Limited
Merck & Co. Inc.
Radius Health, Inc.
Mylan N.V.(Viatris)
Sun Pharmaceutical Industries Ltd.
UCB Biopharma SRL
Dr. Reddy's Laboratories
Strides Pharma Science Limited
EffRx Pharmaceuticals SA
제21장 경쟁 벤치마킹
제22장 경쟁 대시보드
제23장 주요 합병과 인수
제24장 기회와 전략
2029년의 세계 골다공증 치료제 시장 - 가장 새로운 기회를 제공하는 국가
2029년의 세계 골다공증 치료제 시장 - 가장 새로운 기회를 제공하는 부문
2029년의 세계 골다공증 치료제 시장 - 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제25장 골다공증 치료제 시장, 결론·제안
제26장 부록
KSA
영문 목차
영문목차
Osteoporosis drugs are medications designed to prevent, treat, or manage osteoporosis-a condition characterized by decreased bone density and increased susceptibility to fractures. The primary goal of these medications is to strengthen bones, reduce bone loss and lower the risk of fractures.
The osteoporosis drugs market consists of sales, by entities (organizations, sole traders, or partnerships), of osteoporosis drugs that are primarily used by individuals diagnosed with osteoporosis, including postmenopausal women, older adults and patients undergoing treatments that affect bone density, such as long-term corticosteroid therapy.
The global osteoporosis drugs market was valued at $11,436.16 million in 2019 which grew till 2024 at a compound annual growth rate (CAGR) of more than 2.00%.
Health Insurance Expansion
During the historic period, the health insurance expansion supported the growth of the osteoporosis drugs market. Health insurance reduces healthcare costs, increasing affordability and access to osteoporosis medications. Coverage for advanced treatments, such as biologics and injectables, incentivizes patient adoption and supports market growth. By alleviating financial barriers, insurance encourages timely diagnosis and treatment, driving demand for innovative osteoporosis therapies and expanding their market potential. For example, according to PolicyBazaar, an Indian online insurance aggregator and fintech platform, the number of women purchasing term insurance plans in India has witnessed significant growth, with an 80% increase over the past two years. Additionally, insurance penetration in 2023-24 is projected to reach 3.8% in India and 6.5% globally according to Swiss Re. Therefore, the health insurance expansion drove the growth of the osteoporosis drugs market.
Innovative Approaches And Regulatory Approvals Driving Treatment Advancements
Companies in the osteoporosis drugs market are prioritizing the development of innovative solutions, such as obtaining regulatory approvals to enhance treatment outcomes. Regulatory approvals refer to official authorization from health agencies, ensuring new treatments meet safety, efficacy and quality standards before market release. For instance, in November 2024, Teva Pharmaceuticals Inc., a US-based pharmaceutical company received U.S. Food and Drug Administration (FDA) approval for generic version of Forteo (teriparatide injection). This generic medication is recommended for postmenopausal women with osteoporosis at high fracture risk who are unable to use alternative treatments. It is also suitable for men with primary or hypogonadal osteoporosis under similar conditions. Additionally, it applies to both men and women experiencing osteoporosis due to long-term glucocorticoid use, again at high fracture risk and unable to use alternative therapies.
The global osteoporosis drugs market is fairly concentrated, with large players operating in the market. The top ten competitors in the market made up to 39.7% of the total market in 2023.
Osteoporosis Drugs Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global osteoporosis drugs market as it emerges from the COVID-19 shut down.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Where is the largest and fastest-growing market for osteoporosis drugs? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The osteoporosis drugs market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider osteoporosis drugs market; and compares it with other markets.
The report covers the following chapters
Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by administration, by distribution channel and by application.
Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the osteoporosis drugs market.
Global Market Size And Growth- Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
Regional And Country Analysis- Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
Market Segmentation- Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by type, by administration, by distribution channel and by application in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
Regional Market Size and Growth- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Other Major And Innovative Companies Details on the company profiles of other major and innovative companies in the market.
Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
Competitive Dashboard- Briefs on competitive dashboard of major players.
Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations- This section includes recommendations for osteoporosis drugs providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:
1) By Type: Bisphosphonates; Selective Estrogen Receptor Modulators (SERMs); RANK Ligand Inhibitors; Parathyroid Hormone Therapy; Calcitonin; Sclerostin Inhibitor; Other Drug Class
2) By Administration: Oral; Injectable
3) By Distribution Channel: Retail Pharmacies; Hospital Pharmacies; Online Sales
4) By Application: Primary Osteoporosis; Secondary Osteoporosis
Companies Mentioned: Amgen Inc.; Eli Lilly and Company; Pfizer Inc.; Eisai Co., Ltd.; Apotex Inc.
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; osteoporosis drugs indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Table of Contents
1 Executive Summary
1.1 Osteoporosis Drugs - Market Attractiveness And Macro economic Landscape
2 Table Of Contents
3 List Of Tables
4 List Of Figures
5 Report Structure
6 Market Characteristics
6.1 General Market Definition
6.2 Summary
6.3 Osteoporosis Drugs Market Definition And Segmentations
10.1 Global Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
10.2 Global Osteoporosis Drugs Market, Segmentation By Administration, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
10.3 Global Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
10.4 Global Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11 Osteoporosis Drugs Market, Regional and Country Analysis
11.1 Global Osteoporosis Drugs Market, By Region, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.2 Global Osteoporosis Drugs Market, By Country, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12 Asia-Pacific Market
12.1 Summary
12.1.1 Market Overview
12.1.2 Region Information
12.1.3 Market Information
12.1.4 Background Information
12.1.5 Government Initiatives
12.1.6 Regulations
12.1.7 Regulatory Bodies
12.1.8 Major Associations
12.1.9 Taxes Levied
12.1.10 Corporate Tax Structure
12.1.11 Investments
12.1.12 Major Companies
12.2 Asia-Pacific Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.3 Asia-Pacific Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.4 Asia-Pacific Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.5 Asia-Pacific Osteoporosis Drugs Market: Country Analysis
12.6 China Market
12.7 Summary
12.7.1 Market Overview
12.7.2 Country Information
12.7.3 Market Information
12.7.4 Background Information
12.7.5 Government Initiatives
12.7.6 Regulations
12.7.7 Regulatory Bodies
12.7.8 Major Associations
12.7.9 Taxes Levied
12.7.10 Corporate Tax Structure
12.7.11 Investments
12.7.12 Major Companies
12.8 China Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.9 China Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.10 China Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.11 India Market
12.12 India Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.13 India Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.14 India Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.15 Japan Market
12.16 Japan Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.17 Japan Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.18 Japan Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.19 Australia Market
12.20 Australia Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.21 Australia Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.22 Australia Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.23 Indonesia Market
12.24 Indonesia Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.25 Indonesia Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.26 Indonesia Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.27 South Korea Market
12.28 South Korea Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.29 South Korea Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.30 South Korea Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13 Western Europe Market
13.1 Summary
13.1.1 Market Overview
13.1.2 Region Information
13.1.3 Market Information
13.1.4 Background Information
13.1.5 Government Initiatives
13.1.6 Regulations
13.1.7 Regulatory Bodies
13.1.8 Major Associations
13.1.9 Taxes Levied
13.1.10 Corporate tax structure
13.1.11 Investments
13.1.12 Major Companies
13.2 Western Europe Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.3 Western Europe Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.4 Western Europe Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.5 Western Europe Osteoporosis Drugs Market: Country Analysis
13.6 UK Market
13.7 UK Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.8 UK Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.9 UK Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.10 Germany Market
13.11 Germany Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.12 Germany Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.13 Germany Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.14 France Market
13.15 France Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.16 France Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.17 France Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.18 Italy Market
13.19 Italy Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.20 Italy Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.21 Italy Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.22 Spain Market
13.23 Spain Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.24 Spain Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.25 Spain Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14 Eastern Europe Market
14.1 Summary
14.1.1 Market Overview
14.1.2 Region Information
14.1.3 Market Information
14.1.4 Background Information
14.1.5 Government Initiatives
14.1.6 Regulations
14.1.7 Regulatory Bodies
14.1.8 Major Associations
14.1.9 Taxes Levied
14.1.10 Corporate Tax Structure
14.1.11 Investments
14.1.12 Major companies
14.2 Eastern Europe Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.3 Eastern Europe Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.4 Eastern Europe Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.5 Eastern Europe Osteoporosis Drugs Market: Country Analysis
14.6 Russia Market
14.7 Russia Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.8 Russia Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.9 Russia Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15 North America Market
15.1 Summary
15.1.1 Market Overview
15.1.2 Region Information
15.1.3 Market Information
15.1.4 Background Information
15.1.5 Government Initiatives
15.1.6 Regulations
15.1.7 Regulatory Bodies
15.1.8 Major Associations
15.1.9 Taxes Levied
15.1.10 Corporate Tax Structure
15.1.11 Investments
15.1.12 Major Companies
15.2 North America Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.3 North America Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.4 North America Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.5 North America Osteoporosis Drugs Market: Country Analysis
15.6 USA Market
15.7 Summary
15.7.1 Market Overview
15.7.2 Country Information
15.7.3 Market Information
15.7.4 Background Information
15.7.5 Government Initiatives
15.7.6 Regulations
15.7.7 Regulatory Bodies
15.7.8 Major Associations
15.7.9 Taxes Levied
15.7.10 Corporate Tax Structure
15.7.11 Investments
15.7.12 Major Companies
15.8 USA Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.9 USA Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.10 USA Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.11 Canada Market
15.12 Canada Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.13 Canada Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.14 Canada Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16 South America Market
16.1 Summary
16.1.1 Market Overview
16.1.2 Region Information
16.1.3 Market Information
16.1.4 Background Information
16.1.5 Government Initiatives
16.1.6 Regulations
16.1.7 Regulatory Bodies
16.1.8 Major Associations
16.1.9 Taxes Levied
16.1.10 Corporate Tax Structure
16.1.11 Investments
16.1.12 Major Companies
16.2 South America Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.3 South America Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.4 South America Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.5 Brazil Market
16.6 Brazil Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.7 Brazil Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.8 Brazil Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
17 Middle East Market
17.1 Summary
17.1.1 Market Overview
17.1.2 Region Information
17.1.3 Market Information
17.1.4 Background Information
17.1.5 Government Initiatives
17.1.6 Regulations
17.1.7 Regulatory Bodies
17.1.8 Major Associations
17.1.9 Taxes Levied
17.1.10 Corporate Tax Structure
17.1.11 Investments
17.1.12 Major Companies
17.2 Middle East Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
17.3 Middle East Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
17.4 Middle East Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
18 Africa Market
18.1 Summary
18.1.1 Market Overview
18.1.2 Region Information
18.1.3 Market Information
18.1.4 Background Information
18.1.5 Government Initiatives
18.1.6 Regulations
18.1.7 Regulatory Bodies
18.1.8 Major Associations
18.1.9 Taxes Levied
18.1.10 Corporate Tax Structure
18.1.11 Investments
18.1.12 Major Companies
18.2 Africa Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
18.3 Africa Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
18.4 Africa Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
19 Competitive Landscape And Company Profiles
19.1 Company Profiles
19.2 Amgen Inc.
19.2.1 Company Overview
19.2.2 Products And Services
19.2.3 Financial Overview
19.3 Eli Lilly and Company
19.3.1 Company Overview
19.3.2 Products And Services
19.3.3 Financial Overview
19.4 Pfizer Inc.
19.4.1 Company Overview
19.4.2 Products And Services
19.4.3 Financial Overview
19.5 Eisai Co., Ltd.
19.5.1 Company Overview
19.5.2 Products And Services
19.5.3 Financial Overview
19.6 Apotex Inc.
19.6.1 Company Overview
19.6.2 Products And Services
19.6.3 Business Strategy
19.6.4 Financial Overview
20 Other Major And Innovative Companies
20.1 AbbVie Inc.
20.1.1 Company Overview
20.1.2 Products And Services
20.2 Novartis AG
20.2.1 Company Overview
20.2.2 Products And Services
20.3 Sanofi S.A.
20.3.1 Company Overview
20.3.2 Products And Services
20.4 GSK plc
20.4.1 Company Overview
20.4.2 Products And Services
20.5 Daiichi Sankyo Company, Limited
20.5.1 Company Overview
20.5.2 Products And Services
20.6 F. Hoffmann La Roche Ltd.
20.6.1 Company Overview
20.6.2 Products And Services
20.7 Teva Pharmaceutical Industries Limited
20.7.1 Company Overview
20.7.2 Products And Services
20.8 Merck & Co. Inc.
20.8.1 Company Overview
20.8.2 Products And Services
20.9 Radius Health, Inc.
20.9.1 Company Overview
20.9.2 Products And Services
20.10 Mylan N.V. (Viatris)
20.10.1 Company Overview
20.10.2 Products And Services
20.11 Sun Pharmaceutical Industries Ltd.
20.11.1 Company Overview
20.11.2 Products And Services
20.12 UCB Biopharma SRL
20.12.1 Company Overview
20.12.2 Products And Services
20.13 Dr. Reddy's Laboratories
20.13.1 Company Overview
20.13.2 Products And Services
20.14 Strides Pharma Science Limited
20.14.1 Company Overview
20.14.2 Products And Services
20.15 EffRx Pharmaceuticals SA
20.15.1 Company Overview
20.15.2 Products And Services
21 Competitive Benchmarking
22 Competitive Dashboard
23 Key Mergers And Acquisitions
23.1 Bone Health Technologies Acquired Wellen
23.2 Nestle Health Science Acquired Bountiful Company
24 Opportunities And Strategies
24.1 Global Osteoporosis Drugs Market In 2029 - Countries Offering Most New Opportunities
24.2 Global Osteoporosis Drugs Market In 2029 - Segments Offering Most New Opportunities
24.3 Global Osteoporosis Drugs Market In 2029 - Growth Strategies
24.3.1 Market Trend Based Strategies
24.3.2 Competitor Strategies
25 Osteoporosis Drugs Market, Conclusions And Recommendations
